Performance Evaluation of Two Daily Disposable Toric Lens Designs in Habitual Soft Contact Lens Wearers
NCT ID: NCT04831515
Last Updated: 2022-02-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2021-03-29
2021-07-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers
NCT05933772
A Clinical Comparison of Two Multifocal Toric Soft Contact Lenses
NCT06438601
Daily Disposable Toric Comparative Trial in Europe
NCT01070381
The Clinical Study of Silicone Hydrogel Daily Disposable Stenfilcon A Toric Lens
NCT02801006
The Comparative Clinical Performance of Two Daily Disposable Toric Contact Lenses
NCT05020990
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lens A
daily disposable soft contact lens - test lens
Subjects will be randomized to wear test lenses for one week and then cross-over to control lenses for one week.
Lens A
daily disposable soft contact lens - test lens
Lens B
daily disposable soft contact lens - control lens
Lens B
daily disposable soft contact lens - control lens
Subjects will be randomized to wear control lenses for one week and then cross-over to test lenses for one week.
Lens A
daily disposable soft contact lens - test lens
Lens B
daily disposable soft contact lens - control lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lens A
daily disposable soft contact lens - test lens
Lens B
daily disposable soft contact lens - control lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has read and signed an information consent letter;
* Self reports having a full eye examination in the previous two years;
* Anticipates being able to wear the study lenses for at least 12 hours a day, 7 days a week;
* Is willing and able to follow instructions and maintain the appointment schedule;
* Habitually wears toric soft contact lenses binocularly, of any replacement frequency, for the past 3 months minimum;
* Has refractive astigmatism at least -0.75DC in each eye, maximum -2.25DC;
* Has refractive cylinder axis either between 155 to 25 or between 65 and 115 degrees;
* Is myopic and requires a spectacle spherical component of -1.00D to -6.50D inclusively;
* Can be fit and achieve binocular distance vision of at least 20/30 Snellen with the available lens parameters
Exclusion Criteria
* Habitually wears one of the study contact lenses;
* Has any known active ocular disease and/or infection that contraindicates contact lens wear;
* Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
* Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
* Has known sensitivity to the diagnostic sodium fluorescein used in the study;
* Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
* Has undergone refractive error surgery or intraocular surgery.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyndon Jones, PhD, FCOptom
Role: STUDY_DIRECTOR
Centre for Ocular Research and Education
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Golden Optometric Group
Whittier, California, United States
Golden Vision
Sarasota, Florida, United States
Sacco Eye Group
Vestal, New York, United States
Athens Eye Care
Athens, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.